• Home
  • NEW DAY MEDICINE
  • 2 (76) 2025
  • 49 -2 (76) 2025 - Jarylkasynova G.J., Khalimova D.J. - THE SIGNIFICANCE OF TOBACCO CONSUMPTION IN THE DEVELOPMENT OF LIVER AND PANCREATIC DISEASES

49 -2 (76) 2025 - Jarylkasynova G.J., Khalimova D.J. - THE SIGNIFICANCE OF TOBACCO CONSUMPTION IN THE DEVELOPMENT OF LIVER AND PANCREATIC DISEASES

THE SIGNIFICANCE OF TOBACCO CONSUMPTION IN THE DEVELOPMENT OF LIVER AND PANCREATIC DISEASES

Jarylkasynova G.J. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Khalimova D.J. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Resume

This study explored the impact of tobacco consumption on the development of liver and pancreatic diseases. The research included 96 patients (45 with liver diseases and 51 with pancreatic disorders). The analysis focused on tobacco consumption patterns, professional activity, age, and gender distribution. The main symptoms observed were pain (37.2%), anorexia (40%), and obesity (13.7%). Tobacco consumption duration was predominantly over 10 years in the first group (33.3%), while in the second group, it was most common for 5-10 years (34.8%). In conclusion, tobacco consumption significantly increases the risk of liver and pancreatic diseases, emphasizing the importance of early prevention and intervention strategies.

Keywords: tobacco, liver, pancreas, anorexia, obesity.

First page

261

Last page

266

For citation:Jarylkasynova G.J., Khalimova D.J. - THE SIGNIFICANCE OF TOBACCO CONSUMPTION IN THE DEVELOPMENT OF LIVER AND PANCREATIC DISEASES//New Day in Medicine 2(76)2025 261-266 https://https://newdayworldmedicine.com/en/new_day_medicine/2-76-2025

List of References

  1. Абдурахманов Б.И., и соавт. Морфологические изменения печени и поджелудочной железы при применении биологически активных добавок //Узбекистанский медицинский вестник. Ташкент. 2021;1:15-20.
  2. Александрова Е.А. Биологически активные добавки в терапии воспалительных заболеваний органов пищеварения //Вестник гастроэнтерологии. Москва. 2018;10(6):87-92.
  3. Борисов Н.И., и соавт. Токсические поражения печени при хроническом употреблении табака //Вестник патологии. Новосибирск. 2018;3:45-52.
  4. Громов С.В. Экспериментальное изучение влияния табака на пищеварительную систему //Медицинская биология. Казань. 2020;5:89-94.
  5. Andersen H., Jensen P. The impact of smoking on liver diseases: A clinical review //European Journal of Hepatology. London. 2022;34(2):135-142.
  6. Becker G., Müller T. Smoking and its effects on pancreatic function: An updated analysis //Journal of Gastroenterology and Hepatology. Berlin. 2021;19(3):178-184.
  7. Carter J.R., Hansen J. Oxidative stress in the liver caused by nicotine exposure //European Medical Review. Amsterdam. 2023;41(4):210-216.
  8. Davis K.L., Smith R.J. Nicotine-induced pancreatitis: Morphological and biochemical alterations //Journal of Pancreatic Research. London. 2022;26(1):75-81.
  9. Eriksson L., Olofsson A. Chronic inflammation in the liver and pancreas among smokers //Scandinavian Journal of Medicine. Stockholm. 2020;15(2):45-50.
  10. Fischer K., Weber C. The role of smoking in the pathogenesis of liver fibrosis //Journal of Hepatology. Munich. 2023;40(3):160-168.

    file

    download